Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 2
1976 2
1977 2
1979 2
1981 3
1982 3
1983 2
1984 13
1985 11
1986 13
1987 18
1988 15
1989 12
1990 15
1991 23
1992 14
1993 7
1994 16
1995 18
1996 14
1997 30
1998 10
1999 16
2000 36
2001 18
2002 26
2003 28
2004 27
2005 25
2006 24
2007 27
2008 21
2009 23
2010 19
2011 20
2012 15
2013 25
2014 29
2015 20
2016 17
2017 26
2018 16
2019 7
2020 14
2021 5
2022 4
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

715 results

Results by year

Filters applied: . Clear all
Page 1
Bictegravir.
Spagnuolo V, Castagna A, Lazzarin A. Spagnuolo V, et al. Among authors: lazzarin a. Curr Opin HIV AIDS. 2018 Jul;13(4):326-333. doi: 10.1097/COH.0000000000000468. Curr Opin HIV AIDS. 2018. PMID: 29746268 Review.
Bictegravir/emtricitabine/tenofovir alafenamide as initial treatment for HIV-1: five-year follow-up from two randomized trials.
Sax PE, Arribas JR, Orkin C, Lazzarin A, Pozniak A, DeJesus E, Maggiolo F, Stellbrink HJ, Yazdanpanah Y, Acosta R, Huang H, Hindman JT, Martin H, Baeten JM, Wohl D; GS-US-380-1489 and GS-US-380-1490 study investigators. Sax PE, et al. Among authors: lazzarin a. EClinicalMedicine. 2023 May 11;59:101991. doi: 10.1016/j.eclinm.2023.101991. eCollection 2023 May. EClinicalMedicine. 2023. PMID: 37200995 Free PMC article.
Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial.
Gallant J, Lazzarin A, Mills A, Orkin C, Podzamczer D, Tebas P, Girard PM, Brar I, Daar ES, Wohl D, Rockstroh J, Wei X, Custodio J, White K, Martin H, Cheng A, Quirk E. Gallant J, et al. Among authors: lazzarin a. Lancet. 2017 Nov 4;390(10107):2063-2072. doi: 10.1016/S0140-6736(17)32299-7. Epub 2017 Aug 31. Lancet. 2017. PMID: 28867497 Clinical Trial.
Relapse of Symptomatic Cerebrospinal Fluid HIV Escape.
Ferretti F, De Zan V, Gerevini S, Turrini F, Boeri E, Gianotti N, Hasson H, Lazzarin A, Cinque P. Ferretti F, et al. Among authors: lazzarin a. Curr HIV/AIDS Rep. 2020 Oct;17(5):522-528. doi: 10.1007/s11904-020-00526-x. Curr HIV/AIDS Rep. 2020. PMID: 32875516 Review.
Biobanking for COVID-19 research.
Rovere-Querini P, Tresoldi C, Conte C, Ruggeri A, Ghezzi S, DE Lorenzo R, DI Filippo L, Farina N, Ramirez GA, Ripa M, Mancini N, Cantarelli E, Galli L, Poli A, DE Cobelli F, Bonini C, Manfredi AA, Franchini S, Spessot M, Carlucci M, Dagna L, Scarpellini P, Ambrosio A, DI Napoli D, Bosi E, Tresoldi M, Lazzarin A, Landoni G, Martino G, Zangrillo A, Poli G, Castagna A, Vicenzi E, Clementi M, Ciceri F; COVID-BioB Study Group. Rovere-Querini P, et al. Among authors: lazzarin a. Panminerva Med. 2022 Jun;64(2):244-252. doi: 10.23736/S0031-0808.20.04168-3. Epub 2020 Oct 19. Panminerva Med. 2022. PMID: 33073557
Darunavir for the treatment of HIV infection.
Spagnuolo V, Castagna A, Lazzarin A. Spagnuolo V, et al. Among authors: lazzarin a. Expert Opin Pharmacother. 2018 Jul;19(10):1149-1163. doi: 10.1080/14656566.2018.1484901. Epub 2018 Jun 18. Expert Opin Pharmacother. 2018. PMID: 29913082 Review.
Management of HIV infection after triple class failure.
Cossarini F, Spagnuolo V, Gianotti N, Carbone A, Lazzarin A, Castagna A. Cossarini F, et al. Among authors: lazzarin a. New Microbiol. 2013 Jan;36(1):23-39. Epub 2013 Jan 1. New Microbiol. 2013. PMID: 23435813 Free article. Review.
Etravirine for the treatment of HIV infection.
Seminari E, Castagna A, Lazzarin A. Seminari E, et al. Among authors: lazzarin a. Expert Rev Anti Infect Ther. 2008 Aug;6(4):427-33. doi: 10.1586/14787210.6.4.427. Expert Rev Anti Infect Ther. 2008. PMID: 18662109 Review.
A Mobile Application for Exercise Intervention in People Living with HIV.
Bonato M, Turrini F, DE Zan V, Meloni A, Plebani M, Brambilla E, Giordani A, Vitobello C, Caccia R, Piacentini MF, LA Torre A, Lazzarin A, Merati G, Galli L, Cinque P. Bonato M, et al. Among authors: lazzarin a. Med Sci Sports Exerc. 2020 Feb;52(2):425-433. doi: 10.1249/MSS.0000000000002125. Med Sci Sports Exerc. 2020. PMID: 31415448 Clinical Trial.
715 results